Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.

Abstract

p27(Kip1) is a cyclin-dependent kinase inhibitor whose down-regulation has been observed in several tumour models, including breast, colorectal, and gastric carcinomas. The purpose of this study was to assess p27(Kip1) protein expression in normal and benign prostatic epithelia as well as the possible existence of abnormalities in prostate carcinoma progression. p27(Kip1) expression was immunohistochemically analysed in 51 normal tissue samples, 11 nodular hyperplasias (NH), 22 high-grade prostatic intraepithelial neoplasias (PIN), 56 localized prostate adenocarcinomas, and 19 metastases. Immunoblotting was performed in ten cases. Normal prostate epithelium and NH showed diffuse and intense p27(Kip1) nuclear expression in most cases. A significant p27(Kip1) down-regulation was observed in many carcinomas when compared with benign epithelium. Forty-seven cases (84 per cent) were low p27(Kip1) expressors (<50 per cent positive cells) and nine cases (16 per cent) were high p27(Kip1) expressors. p27(Kip1) down-regulation was also consistently seen in PIN. Fourteen out of 19 metastases (74 per cent) were low p27(Kip1) expressors. Six metastatic samples had their corresponding primary tumour analysed and three cases showed decreased expression in the metastasis. It is concluded that p27(Kip1) is constitutively expressed in normal and benign prostatic tissue. This expression is clearly down-regulated in neoplastic progression from the preinvasive lesions through invasive carcinoma and metastases and this therefore occurs in early stages of neoplastic transformation.

• Authors: P L Fernández, Y Arce, X Farré, A Martínez, A Nadal, M J Rey, N Peiró, E Campo, A Cardesa
• Journal: The Journal of pathology (J Pathol) Vol. 187 Issue 5 Pg. 563-6 (Apr 1999) ISSN: 0022-3417 [Print] England
• PMID: 10398122 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright 1999 John Wiley & Sons, Ltd.

Chemical References

• Cell Cycle Proteins
• Enzyme Inhibitors
• Microtubule-Associated Proteins
• Neoplasm Proteins
• Tumor Suppressor Proteins
• Cyclin-Dependent Kinase Inhibitor p27
• Cyclin-Dependent Kinases

Topics

• Adenocarcinoma (metabolism, secondary)
• Aged
• Blotting, Western
• Cell Cycle Proteins
• Cyclin-Dependent Kinase Inhibitor p27
• Cyclin-Dependent Kinases (antagonists & inhibitors)
• Disease Progression
• Down-Regulation
• Enzyme Inhibitors (metabolism)
• Humans
• Male
• Microtubule-Associated Proteins (metabolism)
• Middle Aged
• Neoplasm Proteins (metabolism)
• Prostatic Hyperplasia (metabolism)
• Prostatic Intraepithelial Neoplasia (metabolism)
• Prostatic Neoplasms (metabolism, pathology)
• Tumor Suppressor Proteins